< Terug naar vorige pagina
Onderzoeker
Elisa Claeys
- Disciplines:Morfologische wetenschappen, Oncologie
Affiliaties
- Laboratorium voor RNA Kankerbiologie (Afdeling)
Lid
Vanaf6 jan 2020 → 5 jan 2021 - Laboratorium Virologie en Chemotherapie (Rega Instituut) (Afdeling)
Lid
Vanaf1 okt 2014 → 5 jan 2020
Projecten
1 - 1 of 1
- Immunosuppressieve effecten van een CD4 receptor down-modulator:In vitro studie van de signaalpeptide afhankelijke ER translocatie inhibitor cyclotriazadisulfonamide (CADA)Vanaf1 okt 2014 → 26 sep 2019Financiering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
Publicaties
1 - 6 van 6
- Small Molecule Cyclotriazadisulfonamide Abrogates the Upregulation of the Human Receptors CD4 and 4-1BB and Suppresses In Vitro Activation and Proliferation of T Lymphocytes(2021)
Auteurs: Elisa Claeys, Eva Pauwels, Stephanie Humblet-Baron, Dominique Schols, Mark Waer, Ben Sprangers, Kurt Vermeire
- Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compounds(2020)
Auteurs: Elisa Claeys, Kurt Vermeire
- Immunosuppressive drugs in organ transplantation to prevent allograft rejection: Mode of action and side effects(2019)
Auteurs: Elisa Claeys, Kurt Vermeire
Pagina's: 14 - 21 - Immunosuppressive effects of a CD4 receptor down-modulator: in vitro study of the signal peptide-dependent ER translocation inhibitor cyclotriazadisulfonamide (CADA)(2019)
Auteurs: Elisa Claeys, Kurt Vermeire, Dominique Schols, Mark Waer
- The CD4 Receptor: An Indispensable Protein in T Cell Activation and A Promising Target for Immunosuppression(2019)
Auteurs: Elisa Claeys, Kurt Vermeire
Pagina's: 133 - 150 - A proteomic survey indicates sortilin as a secondary substrate of the ER translocation inhibitor cyclotriazadisulfonamide (CADA)(2017)
Auteurs: Victor Van Puyenbroeck, Elisa Claeys, Dominique Schols, Kurt Vermeire
Pagina's: 157 - 167